子宫肉瘤的临床研究新进展(4)
[9] Amant F，Coosemans A，Debiec-Rychter M，et a1.Clinical management of uterine sarcomas[J]. Lancet Oncol，2009，10(10)：1188-l198.
[10] 白萍，孙建衡. 子宫肉瘤放射治疗的临床观察[J]. 中华妇产科杂志，2001，36(3)：159-161.
[11] Wolfson AH，Brady MF，Rocereto T，et al. A gynecologic oncology group randomized phase II trial of whole abdominal irradiation(WAI)vs cisplatin-ifosfaminal and mesna(CIM) as post-surgical therapy in stage I-IV carcinosarcoma(CS)of the uterus[J]. Gynecol Oncol，2007，107(2)：177-185.
[12] Wade K，Quinn MA，Hammond l，et al. Uterine sarcoma：steroid receptors and response to hormal therapy[J]. Gyecol Oncal，1999，39：364.
[13] Yeh KH，Lu YS，Hsiao CH，et al. High-dose tamoxifen modulates drug resistance to doxorubicin，dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma[J]. Anticancer Res，2003，23(6D)：5l33-5l37.
[14] Siemann DW，Norris CM，Ryan A，et a1.Impact of tumor cell VEGF expression on the In vivo efficacy of vandetanib(ZACTIMA； ZD6474)[J]. Anticancer Res，2009，29(6)：1987-1992.
[15] Kapp DS，Shin JY，Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas：emphasis on impact of lymphadenectomy and oophorectomy[J]. Cancer，2008，112(4)：820-830.
(收稿日期：2013-04-23), http://www.100md.com(仲丽美 姜晓晶)
[10] 白萍，孙建衡. 子宫肉瘤放射治疗的临床观察[J]. 中华妇产科杂志，2001，36(3)：159-161.
[11] Wolfson AH，Brady MF，Rocereto T，et al. A gynecologic oncology group randomized phase II trial of whole abdominal irradiation(WAI)vs cisplatin-ifosfaminal and mesna(CIM) as post-surgical therapy in stage I-IV carcinosarcoma(CS)of the uterus[J]. Gynecol Oncol，2007，107(2)：177-185.
[12] Wade K，Quinn MA，Hammond l，et al. Uterine sarcoma：steroid receptors and response to hormal therapy[J]. Gyecol Oncal，1999，39：364.
[13] Yeh KH，Lu YS，Hsiao CH，et al. High-dose tamoxifen modulates drug resistance to doxorubicin，dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma[J]. Anticancer Res，2003，23(6D)：5l33-5l37.
[14] Siemann DW，Norris CM，Ryan A，et a1.Impact of tumor cell VEGF expression on the In vivo efficacy of vandetanib(ZACTIMA； ZD6474)[J]. Anticancer Res，2009，29(6)：1987-1992.
[15] Kapp DS，Shin JY，Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas：emphasis on impact of lymphadenectomy and oophorectomy[J]. Cancer，2008，112(4)：820-830.
(收稿日期：2013-04-23), http://www.100md.com(仲丽美 姜晓晶)